1. Home
  2. VIR vs WSR Comparison

VIR vs WSR Comparison

Compare VIR & WSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • WSR
  • Stock Information
  • Founded
  • VIR 2016
  • WSR 1998
  • Country
  • VIR United States
  • WSR United States
  • Employees
  • VIR N/A
  • WSR N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • WSR Real Estate Investment Trusts
  • Sector
  • VIR Health Care
  • WSR Real Estate
  • Exchange
  • VIR Nasdaq
  • WSR Nasdaq
  • Market Cap
  • VIR 706.4M
  • WSR 628.6M
  • IPO Year
  • VIR 2019
  • WSR 2010
  • Fundamental
  • Price
  • VIR $5.65
  • WSR $12.60
  • Analyst Decision
  • VIR Strong Buy
  • WSR Strong Buy
  • Analyst Count
  • VIR 8
  • WSR 2
  • Target Price
  • VIR $30.25
  • WSR $15.00
  • AVG Volume (30 Days)
  • VIR 1.2M
  • WSR 252.6K
  • Earning Date
  • VIR 08-04-2025
  • WSR 07-30-2025
  • Dividend Yield
  • VIR N/A
  • WSR 4.29%
  • EPS Growth
  • VIR N/A
  • WSR 26.93
  • EPS
  • VIR N/A
  • WSR 0.61
  • Revenue
  • VIR $20,861,000.00
  • WSR $155,128,000.00
  • Revenue This Year
  • VIR N/A
  • WSR $2.00
  • Revenue Next Year
  • VIR $0.62
  • WSR $5.14
  • P/E Ratio
  • VIR N/A
  • WSR $20.69
  • Revenue Growth
  • VIR N/A
  • WSR 6.69
  • 52 Week Low
  • VIR $4.32
  • WSR $11.78
  • 52 Week High
  • VIR $14.45
  • WSR $15.36
  • Technical
  • Relative Strength Index (RSI)
  • VIR 54.74
  • WSR 52.21
  • Support Level
  • VIR $5.31
  • WSR $12.40
  • Resistance Level
  • VIR $5.92
  • WSR $12.64
  • Average True Range (ATR)
  • VIR 0.30
  • WSR 0.21
  • MACD
  • VIR 0.02
  • WSR -0.00
  • Stochastic Oscillator
  • VIR 43.69
  • WSR 51.04

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

Share on Social Networks: